C van der Zwaan

Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic Events.

P Serruys, P. Serruys, W. O’Neill, 2000, The New England journal of medicine.